molecules of the month


potent, bioavailable autotaxin inhibitor

orally active in fibrosis mod., Ph. I IND cleared

from 225M cmpd DNA-encoded library + opt.

J. Med. Chem., Jul. 23, 2020

X-Chem, Waltham, MA

Structure of X-165, a highly potent and selective small molecule inhibitor of Autotaxin
1 min read

X-165 is an autotaxin inhibitor clinical candidate for idiopathic pulmonary fibrosis discovered using a 3-cycle DEL screen of 225M compounds derived from amide couplings. An unusual spirocyclic amine building block was responsible for most of their non-phosphonate-containing high-enrichment hits. The initially resynthesized hits had single-digit nanomolar potencies in an enzymatic assay, and optimization for ADME properties while maintaining potency led to X-165.

request a trial

You don’t have time to read everything, but you can’t afford to fall behind.

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.

Get ahead now by requesting a trial.

already a member? log in: